Pharmacokinetic and technical comparison of Sandostatin(® )LAR(® )and other formulations of long-acting octreotide

BACKGROUND: Sandostatin(® )LAR(® )(Novartis Pharma AG) is a long-acting repeatable formulation of the somatostatin analogue octreotide, the safety and efficacy of which has been established through 15 years of clinical experience. Recently, other formulations of octreotide using polymer poly(lactic-...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Holger, Bizec, Jean-Claude, Schuetz, Helmut, Delporte, Marie-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212992/
https://www.ncbi.nlm.nih.gov/pubmed/21906300
http://dx.doi.org/10.1186/1756-0500-4-344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212992/
https://www.ncbi.nlm.nih.gov/pubmed/21906300
http://dx.doi.org/10.1186/1756-0500-4-344

Ejemplares similares